Cis-platinum: a new anticancer agent.

This publication has 21 references indexed in Scilit:

• Fluorescent labeling of hormone receptors in viable cells: preparation and properties of highly fluorescent derivatives of epidermal growth factor and insulin.
  Proceedings of the National Academy of Sciences, 1978
• VARIABLES FOR PREDICTING SERIOUS TOXICITY (VINBLASTINE DOSE, PERFORMANCE STATUS, AND PRIOR THERAPEUTIC EXPERIENCE) - CHEMOTHERAPY FOR METASTATIC TESTICULAR CANCER WITH CIS-DICHLORODIAMMINEPLATINUM(II), VINBLASTINE, AND BLEOMYCIN
  1978
• COMBINATION CHEMOTHERAPY FOR OVARIAN CARCINOMA WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND CIS-DICHLORODIAMMINEPLATINUM(II) AFTER FAILURE OF INITIAL CHEMOTHERAPY
  1978
• Noble Metal Complexes in Cancer Chemotherapy
  Published by Springer Nature ,1978
• Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer
  Annals of Internal Medicine, 1977
• CLINICAL RESPONSE AND TOXICITY WITH CIS-DICHLORODIAMMINEPLATINUM(II) IN CHILDREN
  1977
• PHASE-1 STUDY OF HIGH-DOSE CIS-DICHLORODIAMMINEPLATINUM(II) WITH FORCED DIURESIS
  1977
• PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY
  1976
• CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED BLADDER CANCER
  1976
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
  Nature, 1965